Gilead Sciences sets aside $200 million to resolve HIV drug probe
Gilead Sciences set aside $200 million for a potential settlement with federal prosecutors to resolve an investigation into ...
Gilead Sciences Inc. stock outperforms competitors on strong trading day
Gilead Sciences Inc. closed 0.11% below its 52-week high of $112.11, which the company reached on February 25th.
FiercePharma3h
Gilead sets aside $200M for potential settlement over HIV drug speaker program
Weeks after settling a five-year patent dispute with the U.S. | Gilead set aside approximately $200 million for a potential ...
Gilead price target raised to $132 from $115 at Oppenheimer
Oppenheimer raised the firm’s price target on Gilead (GILD) to $132 from $115 and keeps an Outperform rating on the shares. The firm says that ...
Us Weekly1h
Hulu Is Close to Giving ‘Handmaid’s Tale’ Spinoff ‘The Testaments’ a Series Order After New Casting
Hulu is nearing a series order for 'The Handmaid’s Tale' spinoff 'The Testaments' before the hit show's final season ...
Why Gilead Sciences Remains A Buy After A 40% Rally
Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...
Hulu's Handmaid's Tale spin-off finds third lead
The Handmaid’s Tale creator Bruce Miller has reportedly been working on the show for “several years” now, and stepped down as ...
The Handmaid's Tale sequel series casts a major leading role
The Testaments, the sequel series to The Handmaid’s Tale, has cast a major leading role. The upcoming series, based on ...
News241h
The Global Fund will roll out the twice-yearly anti-HIV jab – with or without Pepfar
The Global Fund to Fight AIDS, Tuberculosis and Malaria says it will fund the rollout of the twice-yearly anti-HIV jab, ...
JD Supra48m
Maximizing Patent Term in the United States: Patent Term Adjustment, Patent Term Extension, and the Evolving Law of Obviousness-Type Double Patenting
Under U.S. law, most patents are limited to a term of 20 years from the earliest nonprovisional filing date. However, Patent Term Adjustment (PTA) ...
‘Handmaid’s Tale’ Sequel ‘The Testaments’ Casts Lucy Halliday as Daisy
Hulu’s upcoming series “ The Testaments ,” a sequel to “The Handmaid’s Tale,” has cast Lucy Halliday in the role of Daisy.
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025
Investors eyeing high-growth stocks should consider Corcept Therapeutics, TKO Group, and others with strong earnings ...